EUVIMEDEUVIMED entdecken
Open Access

Clinical Impact and Dynamics of Clonal Hematopoiesis with 177 Lu-PSMA-617 Therapy in Advanced Prostate Cancer

Praful Ravi, Caiwei Zhong, Kimberly J Perez, Wanling Xie, Virginia Volpe, Gwo-Shu Mary Lee, Jonah Boardman, Emma G Pittard, Hailey Stoltenberg, Heather Jacene, Lachelle D Weeks, Adam S Sperling

Journal of Nuclear Medicine · 16.07.2026 · jnumed.126.272125

DOI: 10.2967/jnumed.126.272125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 16.07.2026. Verfasst von Praful Ravi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Boston, Massachusetts; praful_ravi@dfci.harvard.edu asperlin@stanford.edu. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Heterocyclic Compounds, 1-Ring, Dipeptides, Lutetium. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisHeterocyclic Compounds, 1-RingDipeptidesLutetiumProstatic Neoplasms, Castration-ResistantHeterocyclic CompoundsProstatic NeoplasmsHumansMaleAgedMutationAged, 80 and overRadioisotopesProstate-Specific Antigen

Stichwörter der Autor:innen

177Lu-PSMA-617clonal hematopoiesisprostate cancerradiopharmaceutical therapytoxicity

Substanzen

Heterocyclic Compounds, 1-RingDipeptidesPSMA-617LutetiumHeterocyclic CompoundsRadioisotopesProstate-Specific Antigen

Autor:innen und Institutionen

  • Dana-Farber Cancer Institute, Boston, Massachusetts; praful_ravi@dfci.harvard.edu asperlin@stanford.edu.
  • Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Brigham and Women's Hospital, Boston, Massachusetts; and.
  • Stanford University, Palo Alto, California.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Ravi, P., Zhong, C., Perez, K. J., Xie, W., Volpe, V., Lee, G. M., Boardman, J., Pittard, E. G., Stoltenberg, H., Jacene, H., Weeks, L. D., & Sperling, A. S. (2026). Clinical Impact and Dynamics of Clonal Hematopoiesis with 177 Lu-PSMA-617 Therapy in Advanced Prostate Cancer. Journal of Nuclear Medicine, jnumed.126.272125. https://doi.org/10.2967/jnumed.126.272125

Vancouver

Ravi P, Zhong C, Perez KJ, Xie W, Volpe V, Lee GM, et al. Clinical Impact and Dynamics of Clonal Hematopoiesis with 177 Lu-PSMA-617 Therapy in Advanced Prostate Cancer. Journal of Nuclear Medicine. 2026:jnumed.126.272125. doi:10.2967/jnumed.126.272125

BibTeX
@article{Ravi2026,
  author = {Ravi, Praful and Zhong, Caiwei and Perez, Kimberly J and Xie, Wanling and Volpe, Virginia and Lee, Gwo-Shu Mary and Boardman, Jonah and Pittard, Emma G and Stoltenberg, Hailey and Jacene, Heather and Weeks, Lachelle D and Sperling, Adam S},
  title = {Clinical Impact and Dynamics of Clonal Hematopoiesis with 177 Lu-PSMA-617 Therapy in Advanced Prostate Cancer},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  pages = {jnumed.126.272125},
  doi = {10.2967/jnumed.126.272125}
}
Kostenlos starten →